Purpose of the Study: To investigate the role of paraoxonase 1 (PON1) and vitamin E in the pathogenesis of some autoimmune diseases, and to correlate their levels with the disease activity. Procedures: This randomized case control study was performed on 60 subjects: 45 patients [suffering from psoriasis, vitiligo and alopecia areata (AA) 15 patients each group] and 15 healthy controls. Venous blood and tissue biopsy were collected from each subject to estimate the levels of vitamin E and PON1. Results: All patients showed significantly lower levels of both PON1 and vitamin E in tissue and serum than the controls (p < 0.001). Conclusion: An association between oxidative stress and pathogenesis of these autoimmune diseases is identified. Attenuation of oxidative stress might be a relevant therapeutic approach and it would be useful to recommend additional drugs with antioxidant effects in the treatment of these conditions.

Keywords:
Paraoxonase, Vitamin E, Psoriasis, Vitiligo, Alopecia areata
1.
Kavanagh GM, Burton JL, Donnell VO: Effects of dithranol on neutrophil superoxide generation in patients with psoriasis. Br J Dermatol 1996;134:234–237.
2.
Abdel Fattah NS, Ebrahim AA, El Okda ES: Lipid peroxidation/antioxidant activity in patients with alopecia areata. J Eur Acad Dermatol Venereol 2011;25:403–408.
3.
Toker A, Kadi M, Yildirim AK, Aksoy H, Akçay F: Serum lipid profile paraoxonase and arylesterase activities in psoriasis. Cell Biochem Funct 2009;27:176–180.
4.
Shaker ME, Houssen ME, Abo-Hashem EM, Ibrahim TM: Comparison of vitamin E, L-carnitine and melatonin in ameliorating carbon tetrachloride and diabetes induced hepatic oxidative stress. J Physiol Biochem 2009;65:225–233.
5.
Wang G, Cai P, Ansari GA, Khan MF: Oxidative and nitrosative stress in trichloroethene-mediated autoimmune response. Toxicology 2007;229:186–193.
6.
Popov I, Lewin G: A deficient function of the antioxidative system of the organism as an aetiopathogenetic factor in psoriasis. Med Hypotheses 1991;35:229–236.
7.
Passi S, Grandinetti M, Maggio F, Stancato A, De Luca: Epidermal oxidative stress in vitiligo. Pigment Cell Res 1998;11:81–85.
8.
Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M: Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006;160:1–40.
9.
Fredriksson T, Pettersson U: Severe psoriasis – oral therapy with a new retinoid. Dermatologica 1978;157:238–244.
10.
Marks R, Barton SP, Shuttleworth D, Finlay AY: Assessment of disease progress in psoriasis. Arch Dermatol 1989;125:235–240.
11.
Njoo MD, Das PK, Bos JD, Westerhof W: Association of the Köbner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris. Arch Dermatol 1999;135:407–413.
12.
Olsen E, Hordinsky M, McDonald-Hull S, Price V, Roberts J, Shapiro J, Stenn K: Alopecia areata investigational assessment guidelines. National Alopecia Areata Foundation. J Am Acad Dermatol 1999;40:242–246.
13.
Sreekantha, Manjunatha Goud BK, Avinash SS, Amareshwara M, Sudhkar, Vinodchandran: Antioxidant vitamins, calcium and phosphorus levels in psoriasis. Int J Pharma Bio Sci 2010;4:B208–B211.
14.
Naziroglu M, Kokcam I: Antioxidants and lipid peroxidation status in the blood of patients with alopecia. Cell Biochem Funct 2000;18:169–173.
15.
Picardo M, Passi S, Morrone A, Grandinetti M, Di Carlo A, Ippolito F: Antioxidant status in the blood of patients with active vitiligo. Pigment Cell Res 1994;7:110–115.
16.
Mahgoub D, El-Eishi N, Rashed L: Estimation of paraoxonase-1 and superoxide dismutase in vitiligo patients before and after photochemotherapy. J Egypt Wom Dermatol Soc 2012;9:52–56.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.